How race and secondary conditions influence diabetes clinical trial interest
The impact of secondary conditions on clinical trial interest.
Funding Roundup: SubjectWell, Alto Neuroscience, ConnexPay, SUN METALON, Wispr, Paragraph, Merge, InfinyOn, Shadowbox, Electronic Caregiver, And Grafbase.
Clinical trial recruitment platform SubjectWell scores $35M
SubjectWell raises $35M to expand access to clinical trials for cancer and other diseases
Read full article from Austin Inno
Across multiple demographics, accommodations boost patient interest in clinical trial participation and barriers lower interest
Strategies to boost diversity in clinical trials.
Spanish-Speaking Patients Show Strong Interest in Trial Participation in the U.S.
For a clinical trial to be successful, patients need to be the top priority. However, language barriers faced during the clinical trial process can often result in lower participation rates of non-English speakers, an unsatisfactory patient experience and, ultimately, imprecise data. In the US, the leading country in clinical trial participation each year, language barriers are […]
FDA Prioritizes Patient-Reported Outcomes in Clinical Trials
Patient-reported outcomes can help optimize clinical trial design and improve study results.
Why aren’t doctors telling their patients about clinical trials?
Though patients are interested in clinical research, they aren’t talking about clinical trials. Here’s how CROs and sponsors can continue to tap into patient interest.
